Acura Pharma Q4 and FY14 results

• Acura Pharmaceuticals (OTCQB:ACUR -7.5%) Q4 results: Revenues: $0.5M (+999%); COGS: $0.04M (+8.3%); R&D Expense: $0.9M (+12.5%); SG&A: $2M (-28.6%); Operating Loss: ($2.5M) (+28.6%); Net Loss: ($2.7M) (+20.6%); Loss Per Share: ($0.06) (+14.3%).
• FY2014 results: Revenues: $0.8M (+700.0%); COGS: $0.2M (+100.0%); R&D Expense: $4.6M (-6.1%); SG&A: $7.9M (-11.2%); Operating Loss: ($12.2M) (+13.5%); Net Loss: ($13.2M) (+5.0%); Loss Per Share: ($0.27) (+6.9%); Quick Assets: $12.1M.
• No guidance given.